Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2021-05-19 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
普莱柯-2020年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2020 Annual General Meeting Resolution Announcement" for the company 普莱柯生物工程股份有限公司. It details the date and location of the AGM, attendance, voting results on various proposals including the 2020 annual report, board and supervisory reports, financial statements, profit distribution, and other corporate matters. It also includes legal witness statements confirming the legality and validity of the meeting and resolutions. The document is an announcement of the resolutions passed at the AGM rather than the full annual report or financial statements themselves. The length is 3654 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-05-19 Chinese
普莱柯2020年度股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as materials for the 2020 Annual General Meeting (AGM) of 普莱柯生物工程股份有限公司, dated May 2021. It contains detailed meeting instructions, agenda, and multiple proposals for shareholder approval including the 2020 annual report, board and supervisory reports, financial statements, profit distribution, appointment of auditors, and other governance matters. It also includes detailed management and board reports, independent directors' statements, and strategic plans for 2021. The document is lengthy (15,000 characters) and contains substantive content typically presented at an AGM. It is not merely an announcement or a brief summary but the actual meeting materials and reports to be discussed and voted on at the AGM. Therefore, it fits the category of AGM Information (AGM-R).
2021-05-12 Chinese
普莱柯-关于召开2020年度业绩说明会的预告公告
Investor Presentation Classification · 95% confidence The document is a notice announcing the upcoming 2020 annual performance explanation meeting (业绩说明会) for the company 普莱柯生物工程股份有限公司. It references that the 2020 annual report has already been disclosed on April 29, 2021, and this meeting is to provide investors with a more detailed understanding of the company's 2020 operating results and financial status. The document details the meeting time, location, participants, and how investors can join and ask questions. It does not contain actual financial statements or detailed financial analysis itself, but rather is an announcement of a meeting to discuss the annual results. The document length is short (1070 characters), and it fits the pattern of an Investor Presentation (IP) or a meeting announcement. However, since it is specifically an announcement of an earnings explanation meeting (业绩说明会), which is a form of investor presentation focusing on financial results and company performance, the best classification is Investor Presentation (IP).
2021-05-06 Chinese
普莱柯-关于参股公司进入上市辅导备案的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about its associate company entering the listing counseling (辅导备案) phase with the securities regulatory authority. It mentions the acceptance of the listing counseling application and the company's shareholding percentage in the associate. The document is short (573 characters) and serves as a notification of a regulatory event related to the associate company's IPO process, not a financial report or detailed filing. It does not contain financial statements or detailed analysis. This fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-04-29 Chinese
普莱柯-第四届监事会第八次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the supervisory board meeting resolution regarding the company's 2021 first quarter report. It states that the quarterly report complies with regulatory requirements and is truthful, but does not contain the actual financial data or the report itself. The document is short (685 characters) and refers readers to the Shanghai Stock Exchange website for the full report. This fits the pattern of a Regulatory Filing (RNS) as it is an official announcement about the report rather than the report itself.
2021-04-29 Chinese
普莱柯2021年第一季度报告
Interim / Quarterly Report Classification · 95% confidence The document is titled "2021 年第一季度报告" which translates to "2021 First Quarter Report." It contains detailed financial statements including balance sheets, profit and loss statements, cash flow statements, and notes for the first quarter of 2021. The report includes unaudited financial data for the quarter ending March 31, 2021, with comparisons to prior periods. The content is comprehensive and includes substantive financial data and analysis for a period shorter than a full fiscal year, which fits the definition of an Interim / Quarterly Report (IR). There is no indication that this is an announcement or a certification document, and the length and detail confirm it is the report itself, not just a publication announcement or regulatory filing. Therefore, the correct classification is IR with high confidence. Q1 2021
2021-04-29 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.